This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Travis Mickle, President and CEO of KemPharm, Inc. KMPH, was a guest speaker at Benzinga’s All Access on April 29th, 2022.
KemPharm is a pharmaceutical company boasting proprietary technologies that help improve the potential benefits and properties of existing FDA-approved drugs.
Watch the full interview.
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Photo by Adam Nieścioruk on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
